Hx of drug-related anaphylactic reactions, severe allergic reactions related to drug; active diagnosis of uncontrolled airway hyperactivity, uncontrolled asthma, or asthma requiring oral corticosteroids.
Moderate or severe persistent asthma, or a history of asthma within the last  years, or currently has uncontrolled asthma of any classification
Subject has known moderate or severe persistent asthma within the past  years or currently has uncontrolled asthma of any classification\r\n* Subjects who currently have controlled intermittent asthma or controlled mild persistent asthma are allowed in the study
Patients must not have aspirin sensitive asthma
Known chronic obstructive pulmonary disease (COPD) (defined as a forced expiratory volume in  second [FEV] < % of predicted normal), persistent asthma, or a history of poorly controlled asthma within the last  years (controlled intermittent asthma or controlled mild persistent asthma is allowed)
Severe asthma.
Currently being treated with bronchodilators or corticosteroids or known to have active asthma. This will not include patients who suffered from asthma as a child and outgrew it.
Known moderate or severe persistent asthma within the past  years, or uncontrolled asthma of any classification. Note that subjects who currently have controlled intermittent asthma or controlled mild persistent asthma are allowed to participate in the study.
History of asthma that is nonsteroidal anti-inflammatory drug (NSAID)-induced or with asthma that is classified as mild-persistent or worse (based on symptoms occurring more than  days per week)
Known severe hypersensitivity reactions to monoclonal antibodies (Grade ?), any history of anaphylaxis, or uncontrolled asthma (ie,  or more features of partially controlled asthma Global Initiative for Asthma )
Patients with a history of asthma will be excluded
Known moderate or severe persistent asthma within the past  years, or uncontrolled asthma of any classification
Criteria  Known moderate or severe persistent asthma within the past  years
Subject has known moderate or severe persistent asthma within  years, or currently has uncontrolled asthma of any classification; (Note that subjects who currently have controlled intermittent asthma or controlled mild persistent asthma are allowed in the study)
Subject has known moderate or severe persistent asthma within the past  years, or currently has uncontrolled asthma of any classification. NOTE: subjects who currently have controlled intermittent asthma or controlled mild persistent asthma are allowed in the study
Known moderate or severe persistent asthma within the past  years or currently has uncontrolled asthma of any classification
Participant has known chronic obstructive pulmonary disease (COPD) (defined as a forced expiratory volume in  second [FEV] <% of predicted normal), persistent asthma, or a history of asthma within the last  years (controlled intermittent asthma or controlled mild persistent asthma is allowed)
Has moderate or severe persistent asthma within the past  years or uncontrolled asthma of any classification.
Known chronic obstructive pulmonary disease, persistent asthma, or a history of asthma within  years
Participant has known chronic obstructive pulmonary disease (COPD) (defined as a forced expiratory volume in  second [FEV] <% of predicted normal), known moderate or severe persistent asthma within the last  years or currently has uncontrolled asthma of any classification (controlled intermittent asthma or controlled mild persistent asthma is allowed)
History of asthma
Participant has known chronic obstructive pulmonary disease (COPD) with a Forced Expiratory Volume in  second (FEV) less than (<) % predicted normal. Note that FEV testing is required for participants suspected of having COPD and participants must be excluded if FEV <% b) Participant has known moderate or severe persistent asthma within  years (see Attachment : NHLBI table of asthma severity), or currently has uncontrolled asthma of any classification. (Note that participants who currently have controlled intermittent asthma or controlled mild persistent asthma are allowed in the study)
History of drug-related anaphylactic reactions or allergic reactions; subjects with an active diagnosis of uncontrolled airway hyperactivity, uncontrolled asthma, or asthma requiring oral corticosteroids will be excluded
History of asthma
Patients must not have uncontrolled asthma
Asthma or other reactive airway disease
No history of bronchial asthma or related bronchospastic conditions
Participants with persistent asthma as defined by the National Heart, Lung, and Blood Institute.
Participants with persistent asthma as defined by the National Heart, Lung, and Blood Institute
Adult asthma
Clinical diagnosis of asthma
Adult asthma
Participants with persistent asthma as defined by the National Heart, Lung, and Blood Institute
Asthma, wheezing or breathing problems
History of chronic asthma
Patient must not have a history of allergy or bronchial asthma
Uncontrolled asthma or asthma requiring oral corticosteroids.
